Ga offline met de app Player FM !
Haematology series | Acute lymphoblastic leukaemia: Optimising outcomes in adolescent and young adult (AYA) patients
Manage episode 317722615 series 3304844
To start off our mini-series on ALL, this episode we’ll be looking at adolescent and young adult (AYA) patients. Although these patients are commonly seen in the adult setting, evidence suggests that pediatric-inspired regimens may improve their outcomes. But how should these be implemented practically? Joining us this week is Dr Adam DuVall, Assistant Professor of Medicine and specialist in AYA cancer management at the University of Chicago.
Access more free education today! Visit the website, follow us on Twitter (@onckip) or connect on LinkedIn.
References:
- Terwilliger T, Abdul-Hay M. Blood Cancer Journal 2019; 7:e577
- Muffly L, et al. Blood Adv. 2018; 2(8):895-903
- Siegel SE, et al. JAMA Oncol. 2018; 4(5):725-734
- Stock W, et al. Blood. 2019; 133(14):1548-1559
This independent educational activity is supported by educational grants from Servier Pharmaceuticals LLC and Takeda. The educational content has been developed by Liberum IME in conjunction with an independent steering committee; Servier and Takeda have had no influence on the content of this education.
32 afleveringen
Manage episode 317722615 series 3304844
To start off our mini-series on ALL, this episode we’ll be looking at adolescent and young adult (AYA) patients. Although these patients are commonly seen in the adult setting, evidence suggests that pediatric-inspired regimens may improve their outcomes. But how should these be implemented practically? Joining us this week is Dr Adam DuVall, Assistant Professor of Medicine and specialist in AYA cancer management at the University of Chicago.
Access more free education today! Visit the website, follow us on Twitter (@onckip) or connect on LinkedIn.
References:
- Terwilliger T, Abdul-Hay M. Blood Cancer Journal 2019; 7:e577
- Muffly L, et al. Blood Adv. 2018; 2(8):895-903
- Siegel SE, et al. JAMA Oncol. 2018; 4(5):725-734
- Stock W, et al. Blood. 2019; 133(14):1548-1559
This independent educational activity is supported by educational grants from Servier Pharmaceuticals LLC and Takeda. The educational content has been developed by Liberum IME in conjunction with an independent steering committee; Servier and Takeda have had no influence on the content of this education.
32 afleveringen
Alle afleveringen
×Welkom op Player FM!
Player FM scant het web op podcasts van hoge kwaliteit waarvan u nu kunt genieten. Het is de beste podcast-app en werkt op Android, iPhone en internet. Aanmelden om abonnementen op verschillende apparaten te synchroniseren.